Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SF3B3 | Q15393 | 8/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23404543 | 1.00 | SF3B3 (0.44) | SF3B3BRD4CREBBP | |
| SCHEMBL21482590 | 1.00 | SF3B3 (0.44) | SF3B3BRD4CREBBP | |
| SCHEMBL21467367 | 1.00 | SF3B3 (0.44) | SF3B3BRD4CREBBP | |
| SCHEMBL21467366 | 1.00 | SF3B3 (0.44) | SF3B3BRD4CREBBP | |
| SCHEMBL21482637 | 1.00 | SF3B3 (0.44) | SF3B3BRD4CREBBP | |
| SCHEMBL21482698 | 0.93 | SF3B3 (0.43) | SF3B3BRD4CREBBP | |
| SCHEMBL21464716 | 0.93 | SF3B3 (0.43) | SF3B3BRD4CREBBP | |
| SCHEMBL23404451 | 0.90 | SF3B3 (0.42) | SF3B3BRD4CREBBP | |
| SCHEMBL23404455 | 0.90 | SF3B3 (0.42) | SF3B3BRD4CREBBP | |
| SCHEMBL21482591 | 0.90 | SF3B3 (0.42) | SF3B3BRD4CREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210163456-A1 | CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2021-06-03 | — | — | US | disclosed |
| WO-2019199667-A2 | CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE | KEANEY GREGG F (US) | 2019-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210163456-A1 | CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE | PLAAT5, PLAAT3, PLAAT4 | SF3B3 17/4885BRD4 4159/4885CREBBP 2507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.